Xilio Therapeutics, Inc. (XLO)
8.57
+0.22
(+2.63%)
USD |
NASDAQ |
Apr 17, 16:00
8.29
-0.28
(-3.27%)
After-Hours: 20:00
Xilio Therapeutics Free Cash Flow : -5.51M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Johnson & Johnson | 19.70B |
| Merck & Co., Inc. | 12.36B |
| Pfizer Inc. | 9.076B |
| Verastem, Inc. | -147.13M |
| Sensei Biotherapeutics, Inc. | -22.40M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -1.998M |
| Cash from Investing (Quarterly) | -0.095M |
| Cash from Financing (Quarterly) | 35.87M |
| Free Cash Flow Per Share (Quarterly) | -0.1632 |
| Free Cash Flow to Equity (Quarterly) | -1.784M |
| Free Cash Flow to Firm (Quarterly) | -2.093M |
| Free Cash Flow Yield | -2.46% |